SYSTEM AND METHOD FOR EARLY DETECTION OF ALZHEIMERS BY DETECTING AMYLOID-BETA USING ORBITAL ANGULAR MOMENTUM
First Claim
1. An apparatus for measuring a concentration of amyloid-beta within a chiral solution, comprising:
- signal generation circuitry for generating a first signal having an applied first orbital angular momentum signature and applying the first signal to the chiral solution; and
a detector for receiving the first signal after the first signal passes through the chiral solution and determining the concentration of amyloid-beta within the chiral solution based on a detected a detected second orbital angular momentum signature caused by the chiral solution, wherein the second orbital angular momentum signature comprises an amplitude measurement and a phase measurement.
1 Assignment
0 Petitions
Accused Products
Abstract
An apparatus for measuring a concentration of amyloid-beta within a chiral solution includes signal generation circuitry for generating a first signal having an applied first orbital angular momentum signature and applying the first signal to the chiral solution. A detector for receiving the first signal after the first signal passes through the chiral solution and determining the concentration of amyloid-beta within the chiral solution based on a detected second orbital angular momentum signature received from the chiral solution that comprises an amplitude measurement and a phase measurement.
-
Citations
20 Claims
-
1. An apparatus for measuring a concentration of amyloid-beta within a chiral solution, comprising:
-
signal generation circuitry for generating a first signal having an applied first orbital angular momentum signature and applying the first signal to the chiral solution; and a detector for receiving the first signal after the first signal passes through the chiral solution and determining the concentration of amyloid-beta within the chiral solution based on a detected a detected second orbital angular momentum signature caused by the chiral solution, wherein the second orbital angular momentum signature comprises an amplitude measurement and a phase measurement. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 20)
-
-
9. An apparatus for measuring a concentration of amyloid-beta within a chiral solution, comprising:
-
an emitting source for emitting a first signal comprising a plurality of plane waves; orbital angular momentum generation circuitry for receiving the first signal and applying the orbital angular momentum signature to the first signal to provide an orbital angular momentum twisted signal; a transmitter for applying the orbital angular momentum twisted signal to the chiral solution; and a detector for receiving the orbital angular momentum twisted signal after the orbital angular momentum twisted signal passes through the chiral solution and determining the concentration of amyloid-beta within the chiral solution based on a detected second orbital angular momentum signature received caused by the chiral solution, wherein the second orbital angular momentum signature comprises an amplitude measurement and a phase measurement, wherein the detector further comprises; an orbital angular momentum detector for determining the detected signature of the orbital angular momentum by taking the phase measurement and the amplitude measurement within the first signal from the chiral solution; and a processor for determining a concentration of the amyloid-beta within the chiral solution responsive to the detected second orbital angular momentum signature. - View Dependent Claims (10, 11, 12, 13, 14)
-
-
15. A method for detection an early onset of Alzheimer'"'"'s based upon amyloid beta concentration, comprising:
-
generating a first signal having an orbital angular momentum signature applied thereto; applying the first signal to a chiral solution; receiving the first signal after it passes through the chiral solution; detecting a second orbital angular momentum signature within the received first signal, wherein the second orbital angular momentum signature comprises an amplitude measurement and a phase measurement; determining the concentration of amyloid-beta within the chiral solution based on a detected second orbital angular momentum signature comprised of the amplitude measurement and the phase measurement within the first signal received from the chiral solution; and determining if the concentration of amyloid-beta provides an indication of an early onset of Alzheimers. - View Dependent Claims (16, 17, 18, 19)
-
Specification